HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Siong Khoo Selected Research

KW 2170

12/2010A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Siong Khoo Research Topics

Disease

4Neoplasms (Cancer)
12/2010 - 01/2003
2Breast Neoplasms (Breast Cancer)
11/2009 - 08/2006
1Prostatic Neoplasms (Prostate Cancer)
12/2010

Drug/Important Bio-Agent (IBA)

1KW 2170IBA
12/2010
1AndrogensIBA
12/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2010
1ErbB Receptors (EGF Receptor)IBA
11/2009
1StreptavidinIBA
12/2006
1ParaffinIBA
12/2006
1Biotin (Vitamin H)FDA Link
12/2006
1Paclitaxel (Taxol)FDA LinkGeneric
08/2006
1AnthracyclinesIBA
08/2006
1GemcitabineFDA Link
08/2006
1Docetaxel (Taxotere)FDA Link
08/2006
1Indicators and Reagents (Reagents)IBA
01/2003

Therapy/Procedure

1Therapeutics
03/2009